- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Baan enters healthcare with Hiscom purchase
Baan enters healthcare with Hiscom purchaseVanenberg Ventures-the privately held investment arm of enterprise resource planning (ERP) software developer Baan-has purchased Dutch healthcare information systems company Hiscom. Vandenberg Ventures
Baan enters healthcare with Hiscom purchase
Vanenberg Ventures-the privately held investment arm of enterprise resource planning (ERP) software developer Baan-has purchased Dutch healthcare information systems company Hiscom. Vandenberg Ventures and Baan are also based in the Netherlands.
One of Baan's goals with Hiscom is to broaden the firm's current electronic patient record software to allow physicians to manage the complete interaction with the patient by including capabilities such as patient registration, data analysis, laboratory test ordering, and scheduling, said Otto van der Tang, an eight-year Baan veteran who assumed the post of managing director of Hiscom following the acquisition. Support for the management of medical images is also planned, van der Tang said.
"We believe that PACS are going to be an important component of such a patient interaction management system, but we don't believe that we should be developing this product ourselves," he said.
The Dutch firm is in discussion with a PACS software developer for inclusion of its technology in the Hiscom product portfolio.
- Search again
- Homepage
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
